Brian G Atwood's Net Worth

$797 Million

Who is Brian G Atwood?

Brian G Atwood has an estimated net worth of $797 Million. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., INSULET CORP, PHASERX, INC., Trius Therapeutics Inc, PHARMION CORP, XENOGEN CORP, GLAUKOS Corp, VERACYTE, INC., PHOENIX BIOTECH ACQUISITION CORP., Clovis Oncology, Inc., OPGEN INC, Inogen Inc, Atreca, Inc., SECOND SIGHT MEDICAL PRODUCTS INC, Locust Walk Acquisition Corp., NOVACEA INC, GENOMIC HEALTH INC, CADENCE PHARMACEUTICALS INC, FIVE PRIME THERAPEUTICS INC, INTRALASE CORP, Alexza Pharmaceuticals Inc., HELICOS BIOSCIENCES CORP, and Flexion Therapeutics Inc.

SEC CIK

Brian G Atwood's CIK is 0001266567

Past Insider Trading and Trends

2014 was Brian G Atwood's most active year for acquiring shares with 80 total transactions. Brian G Atwood's most active month to acquire stocks was the month of October. 2004 was Brian G Atwood's most active year for disposing of shares, totalling 152 transactions. Brian G Atwood's most active month to dispose stocks was the month of April. 2016 saw Brian G Atwood paying a total of $15,999,990.00 for 2,119,372 shares, this is the most they've acquired in one year. In 2014 Brian G Atwood cashed out on 5,669,788 shares for a total of $3,755,196.45, their largest year based on trade value.